Brought to you by 
Light Chain Bioscience
https://www.lightchainbio.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Light Chain Bioscience
New Designations Set To Speed Hemlibra, CAR-T In China
China is set to grant priority reviews to major biologics from Roche, the first CAR-T therapy from Wuxi Juno, and breakthrough therapy designation to a pediatric respiratory antiviral from ArkBio.
Combined AbbVie/Allergan Makes Earnings Debut
The merger closed in May, so the second quarter earnings report will be the first presentation of the combined company’s performance and outlook.
Getting Its ACT Together: EXACT-Tx Raises NOK155m
EXACT-Tx will use funds from a NOK155m private placing to harness ultrasound in precision therapeutic targeting across a variety of indications and product classes.
Moment Of Truth For Belantamab Mafodotin, Trikafta And Turalio At EMA
A number of drug companies are set to learn the fate of their marketing authorization applications in the EU this week.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- ADMET
- Other Names / Subsidiaries
-
- NovImmune SA